EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische Studie

Long‐term outcome of paediatric anti‐ N ‐methyl‐D ‐ aspartate receptor encephalitis

Lorraine Flet-Berliac iD, Nicolas Tchitchek, Anne Lépine, Anca Florea, Hélène Maurey, Pascale Chrétien, Salima Hacein-Bey-Abina, Frederic Villega, Emmanuel Cheuret, Véronique Rogemond, Géraldine Picard, Jérôme Honnorat und 1 weitere

Developmental Medicine & Child Neurology · 2023-05 · 65 (5) · 691-700

DOI: 10.1111/dmcn.15429 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Developmental Medicine & Child Neurology, online erschienen am 05.10.2022. Verfasst von Lorraine Flet-Berliac und 12 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Neurology Departement, Assistance Publique des Hôpitaux de Paris, Hôpitaux Universitaires Paris-Saclay, Bicêtre Hospital, and Paris-Saclay …. Hauptthemen laut MEDLINE: Anti-N-Methyl-D-Aspartate Receptor Encephalitis, Cognitive Dysfunction. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Hospices Civils de Lyon.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To study long‐term clinical and cognitive outcomes of patients with anti‐ N ‐methyl‐ d ‐aspartate receptor encephalitis (NMDAR‐E), an acute autoimmune neurological disease with severe acute presentations.

Method

In this French multicentre retrospective observational cohort study, patients no older than 18 years with a follow‐up of at least 2 years were included. Data from clinical and cognitive assessments were collected.

Results

Eighty‐one patients were included (57 females, 24 males; median age 10 years 7 months [range 1–18 years], median follow‐up 40 months [range 25–53 months]). At last follow‐up, 35 patients (45%) had cognitive impairment, 48 (70%) had academic difficulties, and 65 (92%) needed rehabilitation. Seventy‐one patients (88%) had a modified Rankin Scale score of no more than 2. A higher number of symptoms at diagnosis was associated with cognitive impairment ( p = 0.01), while an abnormal electroencephalogram at diagnosis increased the risk of academic difficulties ( p = 0.03).

Interpretation

Although most children with NMDAR‐E seemed to recover from motor disabilities, more than 45% had cognitive and academic difficulties. The initial severity of symptoms seems to have an impact on cognition and academic performances. What this paper adds Forty‐five per cent of patients had cognitive impairment at ≥2 years diagnosis of anti‐ N ‐methyl‐ d ‐aspartate receptor encephalitis (NMDAR‐E). Seventy per cent of patients had academic difficulties at ≥2 years diagnosis of NMDAR‐E. Ninety‐two per cent of patients needed rehabilitative care at ≥2 years diagnosis of NMDAR‐E. A high number of symptoms at diagnosis were associated with cognitive impairment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-N-Methyl-D-Aspartate Receptor EncephalitisCognitive DysfunctionMaleFemaleChildHumansInfantRetrospective StudiesCognitionReceptors, N-Methyl-D-Aspartate

Substanzen

Receptors, N-Methyl-D-Aspartate

Autor:innen und Institutionen

  • Pediatric Neurology Departement, Assistance Publique des Hôpitaux de Paris, Hôpitaux Universitaires Paris-Saclay, Bicêtre Hospital, and Paris-Saclay University, Le Kremlin-Bicêtre, France.
  • Immunology-Immunopathology-Immunotherapy (i3), Sorbonne University INSERM, Paris, France.
  • Pediatric Neurology Department, Assistance Publique des Hôpitaux de Marseille, Hôpital Universitaire, Marseille, France.
  • Clinical Immunology Laboratory, Assistance Publique des Hôpitaux de Paris, Hôpitaux Universitaires Paris-Saclay, Bicêtre Hospital, and Paris-Saclay University, Le Kremlin-Bicêtre, France.
  • UTCBS, UMR8258 CNRS-U1267 INSERM, Faculté de Pharmacie de Paris, Université de Paris.
  • Pediatric Neurology Department, CIC 0005, University Children Hospital, Bordeaux.

ORCID-Profile: Lorraine Flet-Berliac

Förderung

  • Hospices Civils de Lyon

Zitieren

APA

Flet-Berliac, L., Tchitchek, N., Lépine, A., Florea, A., Maurey, H., Chrétien, P., Hacein-Bey-Abina, S., Villega, F., Cheuret, E., Rogemond, V., Picard, G., Honnorat, J., & Deiva, K. (2023). Long‐term outcome of paediatric anti‐ N ‐methyl‐D ‐ aspartate receptor encephalitis. Developmental Medicine & Child Neurology, 65(5), 691-700. https://doi.org/10.1111/dmcn.15429

Vancouver

Flet-Berliac L, Tchitchek N, Lépine A, Florea A, Maurey H, Chrétien P, et al. Long‐term outcome of paediatric anti‐ N ‐methyl‐D ‐ aspartate receptor encephalitis. Developmental Medicine & Child Neurology. 2023;65(5):691-700. doi:10.1111/dmcn.15429

BibTeX
@article{FletBerliac2023,
  author = {Flet-Berliac, Lorraine and Tchitchek, Nicolas and Lépine, Anne and Florea, Anca and Maurey, Hélène and Chrétien, Pascale and Hacein-Bey-Abina, Salima and Villega, Frederic and Cheuret, Emmanuel and Rogemond, Véronique and Picard, Géraldine and Honnorat, Jérôme and Deiva, Kumaran},
  title = {Long‐term outcome of paediatric anti‐ N ‐methyl‐D ‐ aspartate receptor encephalitis},
  journal = {Developmental Medicine & Child Neurology},
  year = {2023},
  volume = {65},
  number = {5},
  pages = {691--700},
  doi = {10.1111/dmcn.15429}
}
Kostenlos starten →